Compile Data Set for Download or QSAR
Report error Found 56 Enz. Inhib. hit(s) with all data for entry = 13385
TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785071BDBM785071(2-((5-bromo-2-((4-(N-(1-((2-(2,6-dioxopiperidin-3-...)
Affinity DataIC50: 1.40nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785071BDBM785071(2-((5-bromo-2-((4-(N-(1-((2-(2,6-dioxopiperidin-3-...)
Affinity DataIC50: 1.70nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785073BDBM785073(2-((5-bromo-2-((4-(N-(4-(4-(2-((2-(2,6-dioxopiperi...)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785073BDBM785073(2-((5-bromo-2-((4-(N-(4-(4-(2-((2-(2,6-dioxopiperi...)
Affinity DataIC50: 2.90nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785057BDBM785057(N1-(2-((4-((5-bromo-4-((2-carbamoyl-3-fluorophenyl...)
Affinity DataIC50: 3.70nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785058BDBM785058(N1-(2-((4-((5-bromo-4-((2-carbamoyl-3-fluorophenyl...)
Affinity DataIC50: 3.80nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785047BDBM785047(2-((5-bromo-2-((1-((2-(3-(2-((2-(2,6-dioxopiperidi...)
Affinity DataIC50: 3.80nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785054BDBM785054((2S,4R)-1-((S)-19-((4-((5-bromo-4-((2-carbamoyl-3-...)
Affinity DataIC50: 4.10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785058BDBM785058(N1-(2-((4-((5-bromo-4-((2-carbamoyl-3-fluorophenyl...)
Affinity DataIC50: 4.30nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785055BDBM785055(N1-(2-((4-((5-bromo-4-((2-carbamoyl-3-fluorophenyl...)
Affinity DataIC50: 4.30nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785065BDBM785065(N-(2-((4-((5-bromo-4-((3-oxoisoindolin-4-yl)amino)...)
Affinity DataIC50: 4.70nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785056BDBM785056((2S,4R)-1-((S)-16-((4-((5-bromo-4-((2-carbamoyl-3-...)
Affinity DataIC50: 4.80nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785048BDBM785048(2-((5-bromo-2-((1-((2-(3-(2-(2-((2-(2,6-dioxopiper...)
Affinity DataIC50: 4.80nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785048BDBM785048(2-((5-bromo-2-((1-((2-(3-(2-(2-((2-(2,6-dioxopiper...)
Affinity DataIC50: 4.90nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785047BDBM785047(2-((5-bromo-2-((1-((2-(3-(2-((2-(2,6-dioxopiperidi...)
Affinity DataIC50: 5.10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785057BDBM785057(N1-(2-((4-((5-bromo-4-((2-carbamoyl-3-fluorophenyl...)
Affinity DataIC50: 5.30nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785067BDBM785067(4-((5-bromo-2-((1-((2-(9-((2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 5.70nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785067BDBM785067(4-((5-bromo-2-((1-((2-(9-((2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 5.70nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785065BDBM785065(N-(2-((4-((5-bromo-4-((3-oxoisoindolin-4-yl)amino)...)
Affinity DataIC50: 5.80nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785046BDBM785046(N-(2-((4-((5-bromo-4-((2-carbamoyl-3-fluorophenyl)...)
Affinity DataIC50: 6.40nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50622456BDBM50622456(CHEMBL5409959 | US12466809, Compound 24)
Affinity DataIC50: 6.5nMMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 50622456BDBM50622456(CHEMBL5409959 | US12466809, Compound 24)
Affinity DataIC50: 6.80nMMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785056BDBM785056((2S,4R)-1-((S)-16-((4-((5-bromo-4-((2-carbamoyl-3-...)
Affinity DataIC50: 6.80nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785068BDBM785068(2-((5-bromo-2-((4-(N-(14-((2-(2,6-dioxopiperidin-3...)
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785070BDBM785070(2-((5-bromo-2-((4-(N-(14-((2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 7.10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785049BDBM785049(N-(2-((4-((5-bromo-4-((2-carbamoyl-3-fluorophenyl)...)
Affinity DataIC50: 7.30nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785054BDBM785054((2S,4R)-1-((S)-19-((4-((5-bromo-4-((2-carbamoyl-3-...)
Affinity DataIC50: 7.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785066BDBM785066(N-(2-((4-((5-bromo-4-((3-oxoisoindolin-4-yl)amino)...)
Affinity DataIC50: 7.60nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785070BDBM785070(2-((5-bromo-2-((4-(N-(14-((2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 8.10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785046BDBM785046(N-(2-((4-((5-bromo-4-((2-carbamoyl-3-fluorophenyl)...)
Affinity DataIC50: 8.10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785049BDBM785049(N-(2-((4-((5-bromo-4-((2-carbamoyl-3-fluorophenyl)...)
Affinity DataIC50: 8.40nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785055BDBM785055(N1-(2-((4-((5-bromo-4-((2-carbamoyl-3-fluorophenyl...)
Affinity DataIC50: 9.10nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785066BDBM785066(N-(2-((4-((5-bromo-4-((3-oxoisoindolin-4-yl)amino)...)
Affinity DataIC50: 10.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785068BDBM785068(2-((5-bromo-2-((4-(N-(14-((2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 10.9nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785051BDBM785051(2-((5-bromo-2-((1-((2-(8-((2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 11.8nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785052BDBM785052(2-((5-bromo-2-((1-((2-(6-((2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 13.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785050BDBM785050(2-((5-bromo-2-((1-((2-(9-((2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 16.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785051BDBM785051(2-((5-bromo-2-((1-((2-(8-((2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 17.1nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785060BDBM785060(2-((5-bromo-2-((1-((2-(11-(2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 18.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785072BDBM785072(2-((5-bromo-2-((4-(N-(10-(2-((2-(2,6-dioxopiperidi...)
Affinity DataIC50: 18.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785072BDBM785072(2-((5-bromo-2-((4-(N-(10-(2-((2-(2,6-dioxopiperidi...)
Affinity DataIC50: 19.4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785052BDBM785052(2-((5-bromo-2-((1-((2-(6-((2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 20.5nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785063BDBM785063(N-(2-((4-((5-bromo-4-(3,4-dihydroquinolin-1(2H)-yl...)
Affinity DataIC50: 23.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785063BDBM785063(N-(2-((4-((5-bromo-4-(3,4-dihydroquinolin-1(2H)-yl...)
Affinity DataIC50: 27.4nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785050BDBM785050(2-((5-bromo-2-((1-((2-(9-((2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 28.7nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785059BDBM785059(2-((5-bromo-2-((1-((2-(11-(2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 31.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785060BDBM785060(2-((5-bromo-2-((1-((2-(11-(2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 50nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785059BDBM785059(2-((5-bromo-2-((1-((2-(11-(2-(2,6-dioxopiperidin-3...)
Affinity DataIC50: 57.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-dependent kinase 5 activator 1 [99-307](Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785064BDBM785064(N-(2-((8-((5-bromo-4-((2-carbamoyl-3-fluorophenyl)...)
Affinity DataIC50: 71.3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

TargetCyclin-A2/Cyclin-dependent kinase 2(Human)
Dana-Farber Cancer Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 785064BDBM785064(N-(2-((8-((5-bromo-4-((2-carbamoyl-3-fluorophenyl)...)
Affinity DataIC50: 116nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
3/2/2026
Entry Details
US Patent

Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: